Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
26
MEDP Quote, Financials, Valuation and Earnings
Last price:
$446.33
Seasonality move
:
-5.82%
Day range:
$441.65 - $493.70
52-week range:
$250.05 - $628.92
Dividend yield:
0%
P/E ratio:
29.16x
P/S ratio:
5.21x
P/B ratio:
27.57x
Volume:
1M
Avg. volume:
290.3K
1-year change:
25.82%
Market cap:
$12.7B
Revenue:
$2.5B
EPS (TTM):
$15.30
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B | |
| Revenue Growth (YoY) | 23.38% | 27.8% | 29.17% | 11.84% | 19.97% | |
| Cost of Revenues | $835.3M | $1B | $1.4B | $1.5B | $1.8B | |
| Gross Profit | $307M | $410.1M | $498.2M | $627.1M | $732.5M | |
| Gross Profit Margin | 26.88% | 28.09% | 26.42% | 29.73% | 28.95% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $108.4M | $131.4M | $161.4M | $180.2M | -- | |
| Other Inc / (Exp) | $3.3M | $7.1M | -$655K | $4.1M | -- | |
| Operating Expenses | $108.4M | $131.4M | $161.4M | $180.2M | $197.6M | |
| Operating Income | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Net Interest Expenses | $105K | $2.9M | $488K | -- | -- | |
| EBT. Incl. Unusual Items | $201.9M | $282.9M | $335.7M | $475.9M | $542.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20M | $37.5M | $52.9M | $71.5M | $91.3M | |
| Net Income to Company | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $181.4M | $245.2M | $282.6M | $404.3M | $451.1M | |
| Basic EPS (Cont. Ops) | $5.06 | $7.57 | $9.20 | $13.06 | $15.64 | |
| Diluted EPS (Cont. Ops) | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 | |
| Weighted Average Basic Share | $35.9M | $32.4M | $30.7M | $31M | $28.8M | |
| Weighted Average Diluted Share | $37.7M | $33.7M | $31.8M | $32M | $29.5M | |
| EBITDA | $236M | $319.1M | $363.2M | $476.1M | $563.1M | |
| EBIT | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Revenue (Reported) | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B | |
| Operating Income (Reported) | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Operating Income (Adjusted) | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $308.6M | $394.1M | $498.4M | $536.6M | $708.5M | |
| Revenue Growth (YoY) | 18.82% | 27.73% | 26.47% | 7.66% | 32.03% | |
| Cost of Revenues | $226M | $284.3M | $368.6M | $365.8M | $510.3M | |
| Gross Profit | $82.5M | $109.8M | $129.8M | $170.8M | $198.2M | |
| Gross Profit Margin | 26.74% | 27.87% | 26.05% | 31.83% | 27.98% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $27.7M | $33.4M | $42.5M | $45.4M | -- | |
| Other Inc / (Exp) | $1.1M | -$2M | $1.5M | $621K | -- | |
| Operating Expenses | $27.7M | $33.4M | $42.5M | $45.4M | $44.9M | |
| Operating Income | $54.9M | $76.4M | $87.3M | $125.4M | $153.3M | |
| Net Interest Expenses | $23K | $827K | -- | -- | -- | |
| EBT. Incl. Unusual Items | $55.9M | $73.6M | $90.7M | $133.9M | $156.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.9M | $5M | $12.4M | $16.9M | $21.7M | |
| Net Income to Company | $50M | $68.7M | $78.3M | $117M | $135.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $50M | $68.6M | $78.2M | $117M | $135.1M | |
| Basic EPS (Cont. Ops) | $1.39 | $2.20 | $2.55 | $3.78 | $4.78 | |
| Diluted EPS (Cont. Ops) | $1.32 | $2.12 | $2.46 | $3.67 | $4.67 | |
| Weighted Average Basic Share | $36M | $31.2M | $30.7M | $30.9M | $28.3M | |
| Weighted Average Diluted Share | $37.7M | $32.4M | $31.8M | $31.9M | $29M | |
| EBITDA | $64.7M | $86.9M | $94.3M | $132.9M | $160.4M | |
| EBIT | $54.9M | $76.4M | $87.3M | $125.4M | $153.3M | |
| Revenue (Reported) | $308.6M | $394.1M | $498.4M | $536.6M | $708.5M | |
| Operating Income (Reported) | $54.9M | $76.4M | $87.3M | $125.4M | $153.3M | |
| Operating Income (Adjusted) | $54.9M | $76.4M | $87.3M | $125.4M | $153.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $835.3M | $1B | $1.4B | $1.5B | $1.8B | |
| Gross Profit | $307M | $410.1M | $498.2M | $627.1M | $732.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $108.4M | $131.4M | $161.4M | $180.2M | $152.6M | |
| Other Inc / (Exp) | $3.3M | $7.1M | -$655K | $4.1M | -- | |
| Operating Expenses | $108.4M | $131.4M | $161.4M | $180.2M | $197.6M | |
| Operating Income | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Net Interest Expenses | $105K | $3M | $2.3M | -- | -- | |
| EBT. Incl. Unusual Items | $201.9M | $282.9M | $335.7M | $475.9M | $542.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20M | $37.5M | $52.9M | $71.5M | $91.3M | |
| Net Income to Company | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $181.4M | $245.2M | $282.6M | $404.3M | $451.1M | |
| Basic EPS (Cont. Ops) | $5.06 | $7.60 | $9.20 | $13.06 | $15.65 | |
| Diluted EPS (Cont. Ops) | $4.81 | $7.31 | $8.88 | $12.63 | $15.30 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $236M | $319.1M | $372.8M | $476.1M | $563.1M | |
| EBIT | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Revenue (Reported) | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B | |
| Operating Income (Reported) | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Operating Income (Adjusted) | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.9B | $2.1B | $2.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $1.4B | $1.5B | $1.8B | -- | |
| Gross Profit | $410.1M | $498.2M | $627.1M | $732.5M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $131.4M | $161.4M | $180.2M | $152.6M | -- | |
| Other Inc / (Exp) | $7.1M | -$655K | $4.1M | -$4.7M | -- | |
| Operating Expenses | $131.4M | $161.4M | $180.2M | $197.6M | -- | |
| Operating Income | $278.7M | $336.8M | $446.9M | $534.9M | -- | |
| Net Interest Expenses | $3M | $2.3M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $282.9M | $335.7M | $475.9M | $542.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $37.5M | $52.9M | $71.5M | $91.3M | -- | |
| Net Income to Company | $245.4M | $282.8M | $404.4M | $451.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $245.2M | $282.6M | $404.3M | $451.1M | -- | |
| Basic EPS (Cont. Ops) | $7.60 | $9.20 | $13.06 | $15.65 | -- | |
| Diluted EPS (Cont. Ops) | $7.31 | $8.88 | $12.63 | $15.30 | -- | |
| Weighted Average Basic Share | $129.6M | $122.9M | $123.8M | $115.4M | -- | |
| Weighted Average Diluted Share | $134.7M | $127.3M | $128M | $118.1M | -- | |
| EBITDA | $319.1M | $372.8M | $476.1M | $563.1M | -- | |
| EBIT | $278.7M | $336.8M | $446.9M | $534.9M | -- | |
| Revenue (Reported) | $1.5B | $1.9B | $2.1B | $2.5B | -- | |
| Operating Income (Reported) | $278.7M | $336.8M | $446.9M | $534.9M | -- | |
| Operating Income (Adjusted) | $278.7M | $336.8M | $446.9M | $534.9M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $461.3M | $28.3M | $245.4M | $669.4M | $497M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $186.4M | $253.4M | $298.4M | $296.4M | $402.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $43.2M | $52.3M | $50M | $63.4M | -- | |
| Total Current Assets | $690.9M | $334M | $593.8M | $1B | $989.6M | |
| Property Plant And Equipment | $222.7M | $248.9M | $265.4M | $252.3M | $248.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $662.4M | $662.4M | $662.4M | $662.4M | -- | |
| Other Intangibles | $41.4M | $38M | $35.8M | $34.4M | -- | |
| Other Long-Term Assets | $17.4M | $21.1M | $25M | $22.3M | -- | |
| Total Assets | $1.7B | $1.4B | $1.7B | $2.1B | $2B | |
| Accounts Payable | $25.7M | $33.1M | $31.9M | $32.5M | $28.1M | |
| Accrued Expenses | $101.4M | $138.9M | $217.1M | $222.9M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $27.6M | $47.5M | $40.4M | $53.6M | -- | |
| Total Current Liabilities | $557.2M | $803.5M | $925.1M | $1.1B | $1.3B | |
| Long-Term Debt | $131M | $138.9M | $142.1M | $126.2M | $113.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $707M | $966.1M | $1.1B | $1.3B | $1.5B | |
| Common Stock | $360K | $309K | $308K | $306K | $284K | |
| Other Common Equity Adj | -$4.8M | -$12.4M | -$10.1M | -$14.7M | -- | |
| Common Equity | $952.9M | $386.4M | $559M | $825.5M | $459.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $952.9M | $386.4M | $559M | $825.5M | $459.1M | |
| Total Liabilities and Equity | $1.7B | $1.4B | $1.7B | $2.1B | $2B | |
| Cash and Short Terms | $461.3M | $28.3M | $245.4M | $669.4M | $497M | |
| Total Debt | $131M | $138.9M | $142.1M | $126.2M | $113.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $461.3M | $28.3M | $245.4M | $669.4M | $497M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $186.4M | $253.4M | $298.4M | $296.4M | $402.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $43.2M | $52.3M | $50M | $63.4M | -- | |
| Total Current Assets | $690.9M | $334M | $593.8M | $1B | $989.6M | |
| Property Plant And Equipment | $222.7M | $248.9M | $265.4M | $252.3M | $248.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $662.4M | $662.4M | $662.4M | $662.4M | -- | |
| Other Intangibles | $41.4M | $38M | $35.8M | $34.4M | -- | |
| Other Long-Term Assets | $17.4M | $21.1M | $25M | $22.3M | -- | |
| Total Assets | $1.7B | $1.4B | $1.7B | $2.1B | $2B | |
| Accounts Payable | $25.7M | $33.1M | $31.9M | $32.5M | $28.1M | |
| Accrued Expenses | $101.4M | $138.9M | $217.1M | $222.9M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $27.6M | $47.5M | $40.4M | $53.6M | -- | |
| Total Current Liabilities | $557.2M | $803.5M | $925.1M | $1.1B | $1.3B | |
| Long-Term Debt | $131M | $138.9M | $142.1M | $126.2M | $113.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $707M | $966.1M | $1.1B | $1.3B | $1.5B | |
| Common Stock | $360K | $309K | $308K | $306K | $284K | |
| Other Common Equity Adj | -$4.8M | -$12.4M | -$10.1M | -$14.7M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $952.9M | $386.4M | $559M | $825.5M | $459.1M | |
| Total Liabilities and Equity | $1.7B | $1.4B | $1.7B | $2.1B | $2B | |
| Cash and Short Terms | $461.3M | $28.3M | $245.4M | $669.4M | $497M | |
| Total Debt | $131M | $138.9M | $142.1M | $126.2M | $113.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M | |
| Depreciation & Amoritzation | $37.4M | $40.4M | $26.3M | $29.3M | $28.1M | |
| Stock-Based Compensation | $14.5M | $21.4M | $20.5M | $25.5M | $34.8M | |
| Change in Accounts Receivable | -$25M | -$66.9M | -$48.3M | $2.2M | -$106.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $263.3M | $388.1M | $433.4M | $608.8M | $713.2M | |
| Capital Expenditures | $28.3M | $36.9M | $36.6M | $36.5M | $31.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$31.4M | -$38.7M | -$34.6M | -$28.3M | -$31.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $324.2M | $105M | -- | -- | |
| Long-Term Debt Repaid | -- | -$274.2M | -$155M | -- | -- | |
| Repurchase of Common Stock | $62.1M | $847.8M | $144M | $169.9M | $917.4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$44.5M | -$775.8M | -$182.6M | -$154M | -$860.4M | |
| Beginning Cash (CF) | $461.3M | $28.3M | $245.4M | $669.4M | $497M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $183.5M | -$433M | $217.2M | $424M | -$172.4M | |
| Ending Cash (CF) | $640.9M | -$411.3M | $463.7M | $1.1B | $330.6M | |
| Levered Free Cash Flow | $235.1M | $351.2M | $396.7M | $572.3M | $681.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $50M | $68.7M | $78.3M | $117M | $135.1M | |
| Depreciation & Amoritzation | $9.9M | $10.5M | $7M | $7.5M | $7.1M | |
| Stock-Based Compensation | $4M | $5.6M | $5.2M | $5.9M | $5.6M | |
| Change in Accounts Receivable | $64K | -$4.5M | -$9M | $15.3M | -$29.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $70.9M | $136.7M | $156.4M | $190.7M | $192.7M | |
| Capital Expenditures | $9.1M | $9.2M | $10M | $7.6M | $4.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$9.1M | -$9.2M | -$8M | -$7.6M | -$4.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $25M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$114.7M | -- | -- | -- | |
| Repurchase of Common Stock | -- | $47.2M | -- | $169.9M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2.4M | -$131.1M | $1.5M | -$168.6M | $22.7M | |
| Beginning Cash (CF) | $461.3M | $28.3M | $245.4M | $669.4M | $497M | |
| Foreign Exchange Rate Adjustment | -$1.3M | $915K | $321K | -$2M | $790K | |
| Additions / Reductions | $62.9M | -$2.7M | $150.2M | $12.5M | $211.7M | |
| Ending Cash (CF) | $522.9M | $26.4M | $396M | $680M | $709.5M | |
| Levered Free Cash Flow | $61.8M | $127.4M | $146.4M | $183M | $188.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M | |
| Depreciation & Amoritzation | $37.4M | $40.4M | $26.3M | $29.3M | $28.1M | |
| Stock-Based Compensation | $14.5M | $21.4M | $20.5M | $25.5M | $34.8M | |
| Change in Accounts Receivable | -$25M | -$66.9M | -$48.3M | $2.2M | -$106.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $263.3M | $388.1M | $433.4M | $608.8M | $713.2M | |
| Capital Expenditures | $28.3M | $36.9M | $36.6M | $36.5M | $31.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$31.4M | -$38.7M | -$34.6M | -$28.3M | -$31.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $324.2M | $105M | -- | -- | |
| Long-Term Debt Repaid | -- | -$274.2M | -$155M | -- | -- | |
| Repurchase of Common Stock | $62.1M | $847.8M | $144M | $169.9M | $917.4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$44.5M | -$775.8M | -$182.6M | -$154M | -$860.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $183.5M | -$433M | $217.2M | $424M | -$172.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $235.1M | $351.2M | $396.7M | $572.3M | $681.9M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $245.4M | $282.8M | $404.4M | $451.1M | -- | |
| Depreciation & Amoritzation | $40.4M | $26.3M | $29.3M | $28.1M | -- | |
| Stock-Based Compensation | $21.4M | $20.5M | $25.5M | $34.8M | -- | |
| Change in Accounts Receivable | -$66.9M | -$48.3M | $2.2M | -$106.2M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $388.1M | $433.4M | $608.8M | $713.2M | -- | |
| Capital Expenditures | $36.9M | $36.6M | $36.5M | $31.4M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$38.7M | -$34.6M | -$28.3M | -$31.1M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $324.2M | $105M | -- | -- | -- | |
| Long-Term Debt Repaid | -$274.2M | -$155M | -- | -- | -- | |
| Repurchase of Common Stock | $847.8M | $144M | $169.9M | $917.4M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$775.8M | -$182.6M | -$154M | -$860.4M | -- | |
| Beginning Cash (CF) | $184.7M | $426.7M | $2.2B | $1.3B | -- | |
| Foreign Exchange Rate Adjustment | -$6.6M | $1.1M | -$2.5M | $5.9M | -- | |
| Additions / Reductions | -$433M | $217.2M | $424M | -$172.4M | -- | |
| Ending Cash (CF) | -$254.9M | $645M | $2.7B | $1.1B | -- | |
| Levered Free Cash Flow | $351.2M | $396.7M | $572.3M | $681.9M | -- | |
Get MEDP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MEDP
Sector
P/E ratio
29.16x
23.23x
PEG ratio
1.38x
-0.01x
P/B ratio
27.57x
1.75x
Price / LTM sales
5.21x
1.50x
Growth Metrics
MEDP
Sector
Revenue growth
32.03%
3.24%
Earnings growth
27.2%
10.12%
Revenue (5-year growth)
22.27%
6.27%
Earnings forecast
$4.23
-$0.19
Profitability
MEDP
Sector
Profitability FY 2025
$732.5M
$2.7M
Return on invested capital
73.92%
-33.65%
Return on assets
24.26%
-29.68%
Return on equity
96.22%
-38.98%
Earnings Date
Last Earnings Date
Feb
9
Next Earnings Date
Apr
20
Estimated Next Earnings Date
May
11
Balance Sheet
MEDP
Sector
Total cash
$497M
$25M
Short term investments
--
$23.9M
Total assets
$2B
$72.5M
Long term debt
$113.6M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 12.71% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 1.26% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 3.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
